These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 32826134)

  • 1. Association between weight status, metabolic syndrome, and chronic kidney disease among middle-aged and elderly Chinese.
    Wang Y; Sun B; Sheng LT; Pan XF; Zhou Y; Zhu J; Li X; Yang K; Guo K; Zhang X; He M; Yang H; Wu T; Pan A
    Nutr Metab Cardiovasc Dis; 2020 Oct; 30(11):2017-2026. PubMed ID: 32826134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic obesity phenotypes and chronic kidney disease: a cross-sectional study from the RaNCD cohort study.
    Jam SA; Moloudpour B; Najafi F; Darbandi M; Pasdar Y
    BMC Nephrol; 2022 Jul; 23(1):233. PubMed ID: 35778682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic abnormalities, but not obesity per se, associated with chronic kidney disease in a Taiwanese population.
    Chen HY; Lu FH; Chang CJ; Wang RS; Yang YC; Chang YF; Wu JS
    Nutr Metab Cardiovasc Dis; 2020 Mar; 30(3):418-425. PubMed ID: 31744713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Transition in Metabolic Health and Obesity on the Incident Chronic Kidney Disease: A Nationwide Cohort Study.
    Cho YK; Lee J; Kim HS; Park JY; Lee WJ; Kim YJ; Jung CH
    J Clin Endocrinol Metab; 2020 Mar; 105(3):. PubMed ID: 31967306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolically healthy obesity and risk of incident CKD.
    Hashimoto Y; Tanaka M; Okada H; Senmaru T; Hamaguchi M; Asano M; Yamazaki M; Oda Y; Hasegawa G; Toda H; Nakamura N; Fukui M
    Clin J Am Soc Nephrol; 2015 Apr; 10(4):578-83. PubMed ID: 25635035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic phenotypes and risk of end-stage kidney disease in patients with type 2 diabetes.
    Zhao L; Zou Y; Wu Y; Cai L; Zhao Y; Wang Y; Xiao X; Yang Q; Yang J; Ren H; Tong N; Liu F
    Front Endocrinol (Lausanne); 2023; 14():1103251. PubMed ID: 37234807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of type 2 diabetes, hypertension, and dyslipidemia in metabolically healthy obese and non-obese.
    Fingeret M; Marques-Vidal P; Vollenweider P
    Nutr Metab Cardiovasc Dis; 2018 Oct; 28(10):1036-1044. PubMed ID: 30139688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between obese phenotypes and risk of carotid artery plaque among chinese male railway drivers.
    Pan J; Wang Z; Dong C; Yang B; Tang L; Jia P; Yang S; Zeng H
    BMC Public Health; 2022 Oct; 22(1):1859. PubMed ID: 36199053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of chronic kidney disease in a metabolically healthy obese population.
    Jung CH; Lee MJ; Kang YM; Hwang JY; Kim EH; Park JY; Kim HK; Lee WJ
    Kidney Int; 2015 Oct; 88(4):843-50. PubMed ID: 26108064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Prognosis of Acute Myocardial Infarction Associated With Metabolic Health and Obesity Status.
    Chew NWS; Kong G; Venisha S; Chin YH; Ng CH; Muthiah M; Khoo CM; Chai P; Kong W; Poh KK; Foo R; Yeo TC; Chan MY; Loh PH
    Endocr Pract; 2022 Aug; 28(8):802-810. PubMed ID: 35654337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolically healthy obesity is associated with increased risk of lower urinary tract symptoms secondary to benign prostatic hyperplasia: A cohort study of Chinese elderly males.
    Chen W; Man S; Wang B; Kadeerhan G; Huang X
    Low Urin Tract Symptoms; 2022 May; 14(3):170-177. PubMed ID: 34882977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolically healthy versus unhealthy obese phenotypes in relation to hypertension incidence; a prospective cohort study.
    Hamzeh B; Pasdar Y; Moradi S; Darbandi M; Rahmani N; Shakiba E; Najafi F
    BMC Cardiovasc Disord; 2022 Mar; 22(1):106. PubMed ID: 35287586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in obese metabolic phenotypes over time and risk of incident chronic kidney disease.
    Nam KH; Yun HR; Joo YS; Kim J; Lee S; Lee C; Park KS; Park JT; Chang TI; Kang EW; Yoo TH; Kang SW; Han SH
    Diabetes Obes Metab; 2018 Dec; 20(12):2778-2791. PubMed ID: 29971899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of incident chronic kidney disease in metabolically healthy obesity and metabolically unhealthy normal weight: A systematic review and meta-analysis.
    Iqbal J; Wu HX; Nawaz MA; Jiang HL; Xu SN; Huang BL; Li L; Cai JM; Zhou HD
    Obes Rev; 2024 Feb; 25(2):e13656. PubMed ID: 37904643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity Without Metabolic Abnormality and Incident CKD: A Population-Based British Cohort Study.
    Wang J; Niratharakumar K; Gokhale K; Tahrani AA; Taverner T; Thomas GN; Dasgupta I
    Am J Kidney Dis; 2022 Jan; 79(1):24-35.e1. PubMed ID: 34146618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity and Metabolic Unhealthiness Have Different Effects on Colorectal Neoplasms.
    Ko SH; Baeg MK; Ko SY; Jung HS; Kim P; Choi MG
    J Clin Endocrinol Metab; 2017 Aug; 102(8):2762-2769. PubMed ID: 28510711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural History of Obesity Subphenotypes: Dynamic Changes Over Two Decades and Prognosis in the Framingham Heart Study.
    Echouffo-Tcheugui JB; Short MI; Xanthakis V; Field P; Sponholtz TR; Larson MG; Vasan RS
    J Clin Endocrinol Metab; 2019 Mar; 104(3):738-752. PubMed ID: 30339231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity increases the risk of erosive esophagitis but metabolic unhealthiness alone does not: a large-scale cross-sectional study.
    Baeg MK; Ko SH; Ko SY; Jung HS; Choi MG
    BMC Gastroenterol; 2018 Jun; 18(1):82. PubMed ID: 29884133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic obesity phenotypes: a friend or foe of digestive polyps?-An observational study based on National Inpatient Database.
    Cheng Y; Han J; Li Q; Shi Y; Zhong F; Wu Y; Wang Z; Yuan Z; Fan X; Zhao J
    Metabolism; 2022 Jul; 132():155201. PubMed ID: 35427603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of the dynamic nature of metabolic health status and obesity on risk of incident cardiovascular events and mortality: a nationwide population-based cohort study.
    Cho YK; Kang YM; Yoo JH; Lee J; Park JY; Lee WJ; Kim YJ; Jung CH
    Metabolism; 2019 Aug; 97():50-56. PubMed ID: 31071310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.